BPH Energy Limited logo

BPH Energy Limited (BPH)

Market Open
CXA CXA
- Market Cap
0 P/E Ratio
- Div Yield
100,000 Volume
0 Eps
Want to track BPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BPH is not paying dividends to its shareholders.
BPH Energy Limited has completed 1 stock splits, with the recent split occurring on Mar 30, 2020.
The company's stock is traded on one exchange.

BPH Energy Limited (BPH) FAQ

On which exchange is it traded?

BPH Energy Limited is listed on CXA.

What is its stock symbol?

The ticker symbol is BPH.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has BPH Energy Limited ever had a stock split?

BPH Energy Limited had 1 splits and the recent split was on Mar 30, 2020.

BPH Energy Limited Profile

Capital Markets Industry
Financials Sector
Mr. David Leslie Breeze CEO
CXA Exchange
- ISIN
Australia Country
- Employees
- Last Dividend
30 Mar 2020 Last Split
- IPO Date

Overview

BPH Energy Limited, initially known as BioPharmica Limited, is a publicly traded company that engages in diverse investments across several industries primarily in Australia. With a foundation year of 2001 and headquartered in Stirling, Australia, the company has broadened its investment horizons to include biotechnology, oil and gas exploration and development, as well as the emergent medicinal cannabis sector. Its endeavors also extend to clean energy solutions, emphasizing the development of a system to generate clean hydrogen and conductive carbon for battery manufacturing. Furthermore, BPH Energy is involved in groundbreaking biomedical research, notably in the area of liver cancer through its investment in the study of the HLS5 tumor suppressor gene. The company also has significant interests in the exploration and development of oil and gas assets within Australia.

Products and Services

  • Clean Hydrogen and Conductive Carbon Production System: BPH Energy is invested in creating a system aimed at generating clean hydrogen and conductive carbon, which are essential components for the commercial manufacture of batteries. This initiative underscores the company’s commitment to sustainable energy solutions.
  • Brain Anesthesia Response Monitoring System: This innovative medical device is designed to monitor the effects of anaesthetic agents on brain activity. It assists anaesthetists in maintaining optimal anaesthesia levels for patients during surgery, enhancing patient safety and procedure efficacy.
  • Biomedical Research on HLS5 Tumor Suppressor Gene: A pivotal part of BPH Energy's biotechnological endeavours is its investment in the research of the HLS5 tumor suppressor gene, targeting advancements in liver cancer treatment. This research represents the company’s strong footing in contributing to significant medical breakthroughs.
  • Oil and Gas Exploration and Development: Holding a 100% interest in the onshore RL1 oil and gas assets located in the Bonaparte basin in northern Australia and an 85% interest in the offshore Sydney basin through petroleum exploration permit 11, BPH Energy is deeply engaged in the exploration and development of vital energy resources. This reflects the company’s strategic investments in securing and developing oil and gas assets as part of Australia’s energy portfolio.

Contact Information

Address: 114 Cedric Street
Phone: 61 8 9328 8366